Mark Day: Chief Executive Officer

Dr Day was formally the Executive Director and Head of External Research at Alexion Pharmaceuticals focused on ultra rare diseases. In this role he established the team, developed the strategy and worked to get the endorsement of a venture fund. Prior to this, he led CNS Business Development at BMS and was the responsible for the identification, evaluation and facilitated the acquisition of iPierian for their humanized monoclonal Tau antibody for the treatment of Progressive Supra Nuclear Palsy.

Prior to this, Mark was the Head of Translational Imaging and Biochemical Biomarkers at Abbott Labs, and also led Wyeth’s CNS translational medicine research (identifying and implementing 17 research and development collaborations)

His PhD was conducted at Cardiff University, and his Post Doctoral studies were under Professor RG Morris at The University of Edinburgh. He is an Associate Professor of Neuroscience at Yale University (adjunct).he played published over 60 peer reviewed journal articles. Mark has been highly successful in identifying the best ways to optimize and mobilize internal and external resources to ensure the building of highly motivated and effective teams.


Dr. Reinhard Gabathuler: Chief Scientist

Reinhard has over 25 years experience in research in academia and in early stage development companies (start-ups) and a broad knowledge of scientific research from Plant Biochemistry to Immunology, Oncology and Neurology. He has been very successful in a research results driven environment and is a strong leader with planning and interpretation skills acquired in early stage biotechnology companies.


Dr. Mei Mei Tian: Senior Scientist

Mei Mei is a graduate from The University of British Columbia where she obtained her PhD – Thesis topic MTf – P97. Mei Mei worked on the P97 team at UBC for over 10 years and is a significant contributor to the expanding of our Technology, specifically MTfp.


Ms. Judi Dalling LLB: CFO

Judi Dalling is a retired lawyer with experience in corporate and securities law. She also has a strong accounting background, having been controller and business manager of a major magazine publishing enterprise for over 20 years. Ms. Dalling currently works with various reporting companies, providing legal, accounting and administration services.



Kim Elton: Director of Marketing

Kim Elton has been active in marketing and communications for print, video and online media for more than 30 years. A close ally of biOasis since its inception, Kim is the founder of Strut Media Group, where he works with clients to create clear communications strategies that will achieve maximum impact in an evolving marketplace.